Capalbo, M.; Actis, C.; Maurizia, R.; Brunetto, R.; Poli, G.; Baldi, M.; Palmisano, L.; Verme, G.; Bonino, F. 1992. Treatment of chronic hepatitis B with beta interferon given intramuscularly: A pilot study. Italian Journal of Gastroenterology; 24: 203-205.

Cardon, P. V.; Dommel, F. W.; Trumble, R. R. 1976. Injuries to research subjects: A survey of investigators. The New England Journal of Medicine; 295: 650-654.

Caselmann, W. H. 1989. Beta- and gamma- interferon in chronic active hepatitis B. Gastro enterology; 96: 449-455.

Chalmers, I.; Hetherington, J.; Newdick, M.; Mutch, L.; Grant, A.; Enkin, M.; Enkin, E. 1986. The Oxford database of perinatal trials: Developing a register of published reports of controlled trials. Controlled Clinical Trials; 7: 306-324.

Chattha, G.; Arieff, A. I.; Cummings, C.; Tierney, L. M., Jr. 1993. Lactic acidosis complicating the acquired immunodeficiency syndrome. Annals of Internal Medicine; 118: 37-39.

Chazouilleres, O.; Wright, T. L. in press. Infectious complications of liver transplantation. In: D. Zakim and T. Boyer, Eds. Hepatology: A Textbook of Liver Diseases. Philadelphia, PA: W.B. Saunders Co.

Chen, C-H; Cheng, Y-C. 1989. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine. The Journal of Biological Chemistry; July 15; 264(20): 11934-11937.

Chen, C-H; Vazquez-Padua, M.; Cheng, Y-C. 1991. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Molecular Pharmacology; 39: 625-628.

Code of Federal Regulations 21, parts 300 to 499. 1992. Washington, DC : Office of the Federal Register, National Archives and Records Administration; Revised 1 April.

Colacino, J. M.; Malcom, S. K.; Jaskunas, S. R. 1994. Effect of fialuridine on replication of mitochondrial DNA in CEM cells and in human hepatoblastoma cells in culture. Antimicrobial Agents and Chemotherapy; 38(9): 1997-2002.

Colburn, W. A. 1990. Controversy V: Phase I, First time in man studies. Journal of Clinical Pharmacology; 30: 210-222.

Congress of the United States, House of Representatives (Committee on Government Operations). 1994. Towns says lethal science fiction used in the death of FIAU patients—pledges to expedite subcommittee investigation. Washington, DC: News Release; May 13.

Conte, D.; Barisani, D.; Mandelli, C.; Bodini, P.; Borzio, M.; Pistoso, S.; Segala. M.; Aimo, G. P.; Fraquelli, M.; Bianchi, P. A. 1991. Cholelithiasis in cirrhosis: Analysis of 500 cases. American Journal of Gastroenterology; 86:1629-1632.

Corey, L. 1994. [Letter to FDA. Response letter and appendices to FDA Warning Letter]; June 29.

Cox, D. R. 1972. Regression models and life-tables. Journal of the Royal Statistical Society ; 34:187-220.

Coyle, T. 1993. Letter to the Editor: Response to Chattha et al., Ann Intern Med, 1993;118: 37-39. Annals of Internal Medicine; August 15; 119(4): 344.

Cryer, H. M.; Howard, D. A.; Garrison, R. N. 1985. Liver cirrhosis and biliary surgery: Assessment of risk. Southern Medical Journal; 78: 138-141.